NYU has both strength in genomics, as well as cancer biology, tumor immunology, so that we can integrate all of those disciplines and drive research behind cancer. We also are an academic medical center. The research faculty and the students and the postdocs at NYU have the opportunity to interact with clinicians who are running clinical trials and to learn from them what's really applicable in the clinic so that you can see how the research that happens at NYU can be translated into patient care.
As a student here, you are a part of that journey. You're working with either faculty who are trying to understand cancer cell biology, cancer genome dynamics, or potentially working to understand the epidemiology of cancer in the community and what makes New York unique in that perspective.
The research that postdocs and graduate students are doing here at NYU and at the Perlmutter Cancer Center is really driving how we think about cancer biology and how we think about cancer therapy. They're working with other researchers who are developing biologics, antibodies, CAR T-cells, new immunotherapies that are going to be the future of cancer therapy.
